| Literature DB >> 28887323 |
Abibatou Ndoye1,2, Anna Budina-Kolomets1,3, Curtis H Kugel1, Marie R Webster1, Amanpreet Kaur1,2, Reeti Behera1, Vito W Rebecca3, Ling Li1, Patricia A Brafford1, Qin Liu1, Y N Vashisht Gopal4, Michael A Davies4, Gordon B Mills4, Xiaowei Xu3, Hong Wu5, Meenhard Herlyn1, Michael C Nicastri3, Jeffrey D Winkler3, Maria S Soengas6, Ravi K Amaravadi3, Maureen E Murphy1, Ashani T Weeraratna7.
Abstract
Autophagy mediates resistance to various anticancer agents. In melanoma, resistance to targeted therapy has been linked to expression of Wnt5A, an intrinsic inhibitor of β-catenin, which also promotes invasion. In this study, we assessed the interplay between Wnt5A and autophagy by combining expression studies in human clinical biopsies with functional analyses in cell lines and mouse models. Melanoma cells with high Wnt5A and low β-catenin displayed increased basal autophagy. Genetic blockade of autophagy revealed an unexpected feedback loop whereby knocking down the autophagy factor ATG5 in Wnt5Ahigh cells decreased Wnt5A and increased β-catenin. To define the physiologic relevance of this loop, melanoma cells with different Wnt status were treated in vitro and in vivo with the potent lysosomotropic compound Lys05. Wnt5Ahigh cells were less sensitive to Lys05 and could be reverted by inducing β-catenin activity. Our results suggest the efficacy of autophagy inhibitors might be improved by taking the Wnt signature of melanoma cells into account. Cancer Res; 77(21); 5873-85. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28887323 PMCID: PMC5718045 DOI: 10.1158/0008-5472.CAN-17-0907
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701